Home » Topics » BioWorld Science

BioWorld Science
RSS

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Alnorin reported in phase I

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

CB-30865 selected for further study

April 19, 1996

Onconase development update

April 19, 1996

Terramed receives patent protection for vaccine technology

April 19, 1996

CellCept available in Europe

April 19, 1996

Androgel-DHT in phase II for AIDS indications

April 19, 1996

TNF-bp in clinical testing

April 19, 1996

GEM-91 + AZT enters clinical trials in Europe

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...